Virginia Retirement Systems’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,100
Closed -$109K 1001
2023
Q1
$109K Sell
15,100
-2,500
-14% -$22.2K ﹤0.01% 1002
2022
Q4
$156K Buy
17,600
+4,800
+38% +$52.7K ﹤0.01% 1075
2022
Q3
$157K Buy
+12,800
New +$199K ﹤0.01% 1081
2022
Q1
$249K Sell
13,100
-3,700
-22% -$68.8K ﹤0.01% 1018
2021
Q4
$446 Hold
16,800
﹤0.01% 885
2021
Q3
$690K Buy
16,800
+100
+0.6% +$5.48K 0.01% 725
2021
Q2
$946K Sell
16,700
-2,500
-13% -$92.3K 0.01% 672
2021
Q1
$806K Buy
19,200
+1,700
+10% +$96.8K 0.01% 729
2020
Q4
$1.23M Buy
17,500
+100
+0.6% +$4.11K 0.01% 539
2020
Q3
$488K Buy
+17,400
New +$567K 0.01% 777

Other funds holding EDIT

Virginia Retirement Systems's EDIT Position: Q2 2023 in Review

Virginia Retirement Systems sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 15,100 shares — an estimated $109K sold.

Virginia Retirement Systems first reported a position in EDIT in Q3 2020 and held it in 10 quarters. The position peaked at $1.23M in Q4 2020. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Virginia Retirement Systems reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 15,100 Editas Medicine shares in Q2 2023, an estimated $109K.
  • Virginia Retirement Systems first reported a position in Editas Medicine in Q3 2020 and held it in 10 quarters.
  • Virginia Retirement Systems's Editas Medicine position peaked at $1.23M in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Virginia Retirement Systems's 13F filing for Q2 2023, filed 22 Aug 2023.